The Glasgow prognostic score divides high-risk hematopoietic cell transplantation-specific comorbidity index patients into stratified subgroups in allogeneic hematopoietic cell transplantation
The Glasgow prognostic score divides high-risk hematopoietic cell transplantation-specific comorbidity index patients into stratified subgroups in allogeneic hematopoietic cell transplantation
复制标题
格拉斯哥预后评分将高危造血细胞移植特异性合并症指数患者分为同种异体造血细胞移植中的分层亚组
DOI:
10.1007/s00277-020-03936-4
复制
发表时间:
2020
影响因子:
3.5
通讯作者:
Masuko Masayoshi
中科院分区:
文献类型:
--
作者:
Shibasaki Yasuhiko;Suwabe Tatsuya;Katagiri Takayuki;Fuse Kyoko;Narita Miwako;Sone Hirohito;Masuko Masayoshi
Dear Editor, Although allogeneic hematopoietic cell transplantation (allo-HCT) has the potential to cure patients with hematological disease, it carries risks of non-relapse mortality (NRM). The hematopoietic cell transplantation-specific comorbidity index (HCTCI) is an established index for determining pre-transplant risk stratification before allo-HCT [1]. Because of the high rate of NRM, patients categorized into the high-risk HCT-CI group require careful consideration regarding allo-HCT. Therefore, further stratification of the high-risk HCT-CI group using other factors may be useful to determine the allo-HCT setting. Several biomarkers related to inflammatory and nutritional status, such as serum ferritin (SF), albumin (Alb), and C-reactive protein (CRP), have been reported to be correlated with the prognosis of allo-HCT [2–5]. Among them, the Glasgow prognostic score (GPS), which based on the values of the CRP and Alb [6], is a useful tool for the prediction of prognosis with allo-HCT independent to the HCT-CI [7, 8]. In the present study, we succeeded in dividing the high-risk